Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients

Exclusion Criteria

• •Multi-organ transplant patients
• •HIV positive patients.
• •Living-related liver transplant recipients
• •Pregnant patients
• •Patients with a history of extra-hepatic malignancy within the last five years, except excised squamous or basal cell carcinoma of the skin
• •Patients with thrombocytopenia (\<50,000/mm3), with an absolute neutrophil count of \<1,000/mm3 and/or leukocytopenia (\<2,000/mm3), and/or hemoglobin \<7.0 g/dL prior to enrollment
• •Patients with a G.I. clinical problem at the time of enrollment (e.g. CMV infection or disease, C. difficile colitis, active peptic ulcer disease, gastroenteritis, inflammatory bowel disease)
• •Presence of clinically significant infection requiring continued therapy or uncontrolled diabetes mellitus
• •Evidence of drug and/or alcohol abuse
• •Decisionally impaired subjects who are not medically or mentally capable of providing consent themselves